Results 31 to 40 of about 56,246 (208)

Unusual presentation of recurrent follicular lymphoma as diffuse granular shadow

open access: yesRespirology Case Reports, 2021
A 75‐year‐old man was diagnosed with advanced follicular lymphoma because of enlarged cervical lymph nodes. He received chemotherapy and was in complete remission for four years.
Takayasu Ito   +5 more
doaj   +1 more source

Primary follicular lymphoma of the bladder mimicking inflammatory condition: Case report and review of the literature

open access: yesUrology Case Reports, 2019
Primary lymphoma of the bladder is rare and may present with nonspecific symptoms and infection. Primary follicular lymphoma of the bladder is extremely rare with only a dozen reported cases.
Nina Haghi   +2 more
doaj   +1 more source

Genetic background of relapsing lymphoid neoplasms : comprehensive genetic characterization of primary - relapse pairs by chromosomal copy number and mutational analysis [PDF]

open access: yes, 2016
Diffuse large B-cell lymphoma (DLBCL) is the most frequent tumor of the lymphoid system. Standard first line therapy is successful in the majority of cases, however about 30% of DLBCL are either refractory to it or relapse after a period of ...
Juškevičius, Darius
core   +1 more source

Transformation of a low-grade follicular lymphoma into a composite lymphoma combining a high-grade B-cell lymphoma and a lymphoblastic neoplasm expressing Terminal deoxynucleotidyl Transferase: a case report

open access: yesJournal of Medical Case Reports, 2020
Background High-grade B-cell lymphoma with rearrangements of MYC and BCL2 and/or BCL6 is an aggressive mature B-cell neoplasm, whereas B-lymphoblastic lymphoma is immature cell proliferation, with a frequent positivity for terminal deoxynucleotidyl ...
Antonin Bouroumeau   +11 more
doaj   +1 more source

Molecular Pathogenesis of MALT lymphoma

open access: yes, 2011
Mucosa associated lymphoid tissue (MALT) lymphoma is characterized by t(11;18)(q21;q21)/API2-MALT1, t(1;14)(p22;q32)/BCL10-IGH and t(14;18)(q32;q21)/IGH-MALT1, which commonly activate the NF-κB pathway.

core   +1 more source

Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma : endpoints of a spectrum of one disease?

open access: yes, 2013
In contrast to the commonly indolent clinical behavior of nodular lymphocyte predominant Hodgkin lymphoma (NLPHL), T cell/histiocyte rich large B cell lymphoma (THRLBCL) is frequently diagnosed in advanced clinical stages and has a poor prognosis ...
Benjamin Rengstl   +41 more
core   +1 more source

Follicular lymphoma transforming to DLBCL and reverting back to follicular lymphoma at relapse—a case report

open access: yesJournal of the Egyptian National Cancer Institute, 2020
Background Transformation of low-grade follicular lymphoma to high-grade diffuse large B cell lymphoma (DLBCL) is known. However, the opposite is not commonly reported.
M. C. Suresh Babu   +11 more
doaj   +1 more source

Follicular lymphoma

open access: yesAnnals of Oncology, 2010
Follicular lymphoma is an indolent and usually incurable disease. It has been therefore traditionally approached either by watch and wait or with single-agent treatments. The purpose was to maintain a good quality of life for a prolonged time. More aggressive regimens, including polychemotherapy, high-dose chemotherapy with stem-cell rescue and the ...
openaire   +3 more sources

Mesenteric follicular lymphoma [PDF]

open access: yesClinical Case Reports, 2019
AbstractWhen you see a patient with solid mesenteric tumors, malignant lymphoma should be considered as an important differential diagnosis. It is essential to include abdominal CT and 18F‐FDG PET/CT examinations in these patients for early diagnosis of malignant lymphoma, giving extra weight on patients' complaints.
Yoshito Nishimura   +3 more
openaire   +3 more sources

Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection

open access: yes, 2010
Rituximab, a monoclonal antibody which targets CD20 on B-cells, is now central to the treatment of a variety of malignant and autoimmune disorders. Despite this success a substantial proportion of B-cell lymphomas are unresponsive or develop resistance ...
French, R.R.   +31 more
core   +1 more source

Home - About - Disclaimer - Privacy